US 6,472,420 B2Granted

Method for treating a patient with neoplasia by treatment with a paclitaxel derivative

AssigneeCell Pathways, Inc.

InventorsRifat Pamukcu, Kerstin B. Menander

Life of this patent

Estimating the term…

Abstract

This invention provides a method for treating a patient with neoplasia by an adjuvant therapy that includes treatment with a paclitaxel derivative.

Claims3

Dependent claims

A method of treating a patient with neoplastic cells comprising causing cyclic GMP to increase in the neoplastic cells and exposing said neoplastic cells to a paclitaxel derivative.

Dependencies are inferred from the claim text.

Facts

Application: 10/038,634Filed 3 Jan 2002 · division
Priority: 12 Nov 1998
Published: US 2002/0137722 A126 Sep 2002
Granted: 29 Oct 2002
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

A61K 31/28
Medicinal preparations containing organic active ingredients: compounds containing heavy metals
A61K 33/243
Heavy metals; Compounds thereof: platinum; Compounds thereof
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61K 51/0491
Organic compounds: sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers

Family

Application09/190,830Parent of this continuation · filed 12 Nov 1998
Application09/777,359Parent of this division · filed 6 Feb 2001
US 2002/0137722 A1Pre-grant publication · published 26 Sep 2002
US 6,365,627 B2Parent of this division
Application09/777,359Parent of this continuation
US 6,235,782 B1Parent of this continuation
US 2001/0021720 A1Published application
US 6,472,420 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results